AR MedTech firm Augment Therapy raised USD 2.7 million in a seed plus funding round from existing and new investors, including BlueTree Capital Group, CareSource, VisionTech, and various angel investors.
The funds will be used to expand Augment Therapy's product line, improve research validation, and bolster market traction.
Augment Therapy specializes in immersive and gamified technology for rehabilitative healthcare, backed by full-body skeletal tracking. Its products include ARWell PRO, which caters to healthcare providers and patients, and ARWell, which caters to general wellness exercises.
Analyst QuickTake: Other XR MedTech companies that recently raised funding include apoQlar in July 2023 (for its medical mixed reality software), Augmedics’ USD 82.5 million Series D funding in June 2023 (to scale its AR surgical guidance solutions), and Medivis’ USD 20 million Series A funding in June 2023 (to obtain regulatory approval for its AR surgical imaging platform).
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.